A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer
For more information about the trial above please contact the study team:
Principal Investigator, Harriet Eldredge-Hindy, at email@example.com.
Study Coordinator, Alexandria Green, at firstname.lastname@example.org.
Trial opened at the following institutions: Medical University of South Carolina